Inhibition of SK3 channels in the TE671 human medulloblastoma cell line by desipramine and imipramine

Eur J Pharmacol. 2002 Jul 19;448(2-3):139-42. doi: 10.1016/s0014-2999(02)01971-4.

Abstract

The TE671 human medulloblastoma cell line endogenously expresses SK3 channels. Using patch clamp, we tested the effects on this current of desipramine and imipramine. In both cases, we observed a complete, reversible and concentration-dependent block. The interaction of desipramine with the selective SK3 blocker, apamin, was studied in more detail. Co-application of desipramine and apamin at concentrations close to their IC(50) produced an additive effect that was significantly higher than that of each compound alone. This effect was also observed at IC(25) concentrations. Collectively, these data provide evidence against a common site of action for desipramine and apamin.

MeSH terms

  • Desipramine / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Imipramine / pharmacology*
  • Medulloblastoma / metabolism*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels / metabolism*
  • Potassium Channels / physiology*
  • Potassium Channels, Calcium-Activated*
  • Small-Conductance Calcium-Activated Potassium Channels
  • Tumor Cells, Cultured

Substances

  • KCNN3 protein, human
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Calcium-Activated
  • Small-Conductance Calcium-Activated Potassium Channels
  • Imipramine
  • Desipramine